Varma Mutual Pension Insurance Co bought a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 399,574 shares of the company’s stock, valued at approximately $51,345,000. Varma Mutual Pension Insurance Co owned about 0.31% of Merck KGaA at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Gables Capital Management Inc. acquired a new stake in Merck KGaA during the 2nd quarter worth $2,095,000. Diversify Advisory Services LLC acquired a new stake in shares of Merck KGaA in the second quarter valued at about $3,810,000. Danske Bank A S acquired a new stake in shares of Merck KGaA in the second quarter valued at about $276,535,000. Danica Pension Livsforsikringsaktieselskab purchased a new position in shares of Merck KGaA in the second quarter worth about $25,541,000. Finally, BOK Financial Private Wealth Inc. purchased a new position in shares of Merck KGaA in the second quarter worth about $523,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
OTCMKTS:MKGAF opened at $163.21 on Friday. Merck KGaA has a one year low of $116.68 and a one year high of $175.56. The stock has a market cap of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The stock has a 50 day moving average price of $162.62 and a 200 day moving average price of $148.46.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
